Skip Navigation

JNCI Journal of the National Cancer Institute 1996 88(12):832-835; doi:10.1093/jnci/88.12.832
© 1996 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Curtis, R. E.
Right arrow Articles by Fraumeni, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtis, R. E.
Right arrow Articles by Fraumeni, J. F., Jr
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Second Cancers After Adjuvant Tamoxifen Therapy for Breast Cancer

Rochelle E. Curtis, John D. Boice, Jr., Donna A. Shriner, Benjamin F. Hankey, and Joseph F. Fraumeni, Jr

You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article

Article topics:

  • Oncology..Tamoxifen
  • Oncology..Treatment Options for Breast Cancer
  • Medicine..Breast Issues
  • Oncology..Epidemiology, Causes, and Risk Factors of Breast Cancer
  • Oncology..Breast Cancer
  • Oncology..Treatment Options for Stomach / Gastric Cancer
  • Oncology..Chemoprevention
  • Oncology..Clinical Trials (Prevention)
  • Oncology..Prevention of Cancer
  • Oncology..Incidence
  • Oncology..Adjuvants
  • Oncology..Treatment Options for Liver Cancer
  • Oncology..Second Cancers
  • Medicine..Treatment Options for Leukemia
  • Medicine..Prevention of Breast Cancer
  • Oncology..Epidemiology, Causes, and Risks of Stomach / Gastric Cancer
  • Oncology..Epidemiology, Causes, and Risks of Liver Cancer
  • Oncology..Epidemiology, Causes, and Risks of Leukemia

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 MutagenesisHome page
K. Brown
Is tamoxifen a genotoxic carcinogen in women?
Mutagenesis, September 1, 2009; 24(5): 391 - 404.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W. Chu, A. Fyles, E. M. Sellers, D. R. McCready, J. Murphy, T. Pal, and S. A. Narod
Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use
Carcinogenesis, October 1, 2007; 28(10): 2139 - 2142.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Gerber, A. Krause, T. Reimer, I. Mylonas, J. Makovitzky, G. Kundt, and W. Janni
Anastrozole versus Tamoxifen Treatment in Postmenopausal Women with Endocrine-Responsive Breast Cancer and Tamoxifen-Induced Endometrial Pathology
Clin. Cancer Res., February 15, 2006; 12(4): 1245 - 1250.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. J. Swerdlow, M. E. Jones, and For the British Tamoxifen Second Cancer Study Grou
Tamoxifen Treatment for Breast Cancer and Risk of Endometrial Cancer: A Case-Control Study
J Natl Cancer Inst, March 2, 2005; 97(5): 375 - 384.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
R. E. Curtis, D. M. Freedman, M. E. Sherman, and J. F. Fraumeni Jr.
Risk of Malignant Mixed Mullerian Tumors After Tamoxifen Therapy for Breast Cancer
J Natl Cancer Inst, January 7, 2004; 96(1): 70 - 74.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
M. C. Poirier and L. J. Schild
The Genotoxicity of Tamoxifen: Extent and Consequences, Kona, Hawaii, January 23, 2003
Mutagenesis, July 1, 2003; 18(4): 395 - 399.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. Auvinen, R. E. Curtis, and E. Ron
Risk of Subsequent Cancer Following Breast Cancer in Men
J Natl Cancer Inst, September 4, 2002; 94(17): 1330 - 1332.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
E. J. Suh-Burgmann and A. Goodman
Surveillance for Endometrial Cancer in Women Receiving Tamoxifen
Ann Intern Med, July 20, 1999; 131(2): 127 - 135.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Curtis, R. E.
Right arrow Articles by Fraumeni, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtis, R. E.
Right arrow Articles by Fraumeni, J. F., Jr
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?